Answers are grounded in this paper and cite their sources.
Case report demonstrates successful air travel management in a patient with malignant hydropneumothorax using an IPC, suggesting feasible travel options.
Introduction Air travel is generally contraindicated in pneumothorax due to cabin pressure-related gas expansion and risk of deterioration; guidelines recommend delaying travel until radiographic resolution plus a waiting period. Co-existing pneumothoraces are common in individuals with malignant pleural effusion (MPE), due to non-expandable lung (NEL) or procedural complications. Indwelling pleural catheters (IPCs) are a common treatment for recurrent MPE, yet strategies for safely managing hydropneumothorax during a flight are unreported. Herein we describe an individual with malignant hydropneumothorax who undertook air travel with an IPC. Case A man in his 70s with malignant pleural mesothelioma developed a large left hydropneumothorax following drainage of MPE (Figure 1). He had a history of chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in one second (FEV1) of 1.05 L (47% predicted). His room air oxygen saturation was 94%. After discussion, an IPC was inserted for outpatient management. Soon after the procedure, he expressed a wish to take a 3-hour domestic flight with his family. After consultation with the treating team, a protocol was established: attach a clamped IPC drainage bag before boarding, with instructions to unclamp if dyspnoea or chest pain developed. At cruising altitude (∼8000 ft), he became breathless, unclamped the system, and drained air and 125 mL of fluid achieving immediate relief. The remainder of the flight was uneventful; on the return trip, no drainage was required. He died seven months later from disease progression, having fulfilled a final family trip. Discussion By Boyle’s law, intrapleural gas volume expands by ∼25% at typical cabin pressure; controlled release through an IPC can decompress the chest and relieve pressure increases. Prior case reports describe pneumothorax managed with chest drains or one-way valves during flight, but none report in-flight, patient-directed IPC use for hydropneumothorax. In our case, the IPC served a dual purpose: symptom palliation via ambulatory drainage and physiological pressure relief during air travel. Conclusion For selected patients with malignant hydropneumothorax and a functioning IPC, air travel may be feasible and safe. Beyond physiological considerations, this case underscores the value of flexible and patient-centred care, enabling compassionate, meaningful travel for those with terminal disease. Figure 1: Chest radiograph demonstrating the left-sided hydropneumothorax. Arrowheads denote the visceral line caused by partial collapse of the lower lobe; the asterisk indicates the hilar mass secondary to near-total upper lobe collapse; the “X” marks the dependent pleural effusion; and the white arrow points to the IPC.
No takes yet. Share an insight, caveat, or question.
Duong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: